Basal forebrain in the context of schizophrenia

Brain Research Reviews

Volumn 31, Issue 2-3, 2000, Pages 205-235

  Heimer, Lennart ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Basal forebrain; Basal nucleus of Meynert; Extended amygdala; Schizophrenia; Ventral striatum

Indexed keywords

AMYGDALOID NUCLEUS; ANATOMY; BASAL GANGLION; BRAIN DEVELOPMENT; CLINICAL FEATURE; COGNITIVE DEFECT; CONFERENCE PAPER; CORPUS STRIATUM; FOREBRAIN; GLOBUS PALLIDUS; HUMAN; HYPOTHESIS; MAGNOCELLULAR NUCLEUS; NERVE CELL NETWORK; NERVE PROJECTION; NEUROPATHOLOGY; NEUROPSYCHIATRY; NUCLEUS ACCUMBENS; PEDUNCULAR ANSA; PRIORITY JOURNAL; SCHIZOPHRENIA; STRIA TERMINALIS;

AMYGDALA; ANIMALS; BASAL GANGLIA; BASAL NUCLEUS OF MEYNERT; HUMANS; NUCLEUS ACCUMBENS; SCHIZOPHRENIA;

EID: 0034010691     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(99)00039-9     Document Type: Conference Paper

References (193)

1. Abelson J.L. Cholecystokinin in psychiatric research: A time for cautious excitement. J. Psychiat. Res. 29:1995;389-396.
2. Alexander G.E., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci. 9:1986;357-381.
3. Alheid G.F., Beltramino C.A., de Olmos J.S., Forbes M.S., Swanson D.J., Heimer L. The neuronal organization of the supracapsular part of the stria terminalis in the rat: The dorsal component of extended amygdala. Neuroscience. 84:1998;967-996.
4. G.F. Alheid, J.S. de Olmos, C.A. Beltramino, Amygdala and extended amygdala, in: G. Paxinos (Ed.), The Rat Nervous System, 2nd Ed, Academic Press, San Diego, 1995, pp. 495-578.
5. Alheid G.F., Heimer L. New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata. Neuroscience. 27:1988;1-39.
6. G.F. Alheid, L. Heimer, R.C. Switzer, Basal Ganglia, in: G. Paxinos (Ed.), The Human Nervous System, Academic Press, San Diego, CA, 1990, pp. 483-582.
7. Amaral D.G., Insausti R. Retrograde transport of D-[3H]-aspartate injected into the monkey amygdaloid complex. Exp. Brain Res. 88:1992;375-388.
8. D.G. Amaral, J.L. Price, A. Pitkanen, S.T. Carmichael, Anatomical organization of the primate amygdaloid complex, in: J.P. Aggleton (Ed.), The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction, Wiley-Liss, New York, 1992, pp. 1-66.
9. Arendt T., Bigl V., Arendt A., Tennstedt A. Loss of neurons in the nucleus basalis of Meynert in Alzheimer disease. Ann. Neurol. 10:1983;499-505.
10. Arendt T., Marcova L., Bigl V., Bruckner M.K. Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. I. Dendritic organisation of the normal human basal forebrain. J. Comp. Neurol. 351:1995;169-188.
11. Armstrong D.M., Saper C.B., Levey A.I., Wainer B.H., Terry R.D. Distribution of cholinergic neurons in rat brain: demonstrated by the immunocytochemical localization of choline acetyltransferase. J. Comp. Neurol. 216:1983;53-68.
12. Averback P. Lesions of the nucleus ansae peduncularis in neuropsychiatric disease. Arch. Neurol. 38:1981;230-235.
13. Ayala G. A hitherto undifferentiated nucleus in the forebrain (nucleus subputaminalis). Brain. 37:1915;433-448.
14. Beach T.G., McGeer E.G. The distribution of substance P in the primate basal ganglia: An immunohistochemical study of baboon and human brain. Neuroscience. 13:1984;29-52.
15. Bennett-Clarke C.A., Joseph S.A. Immunocytochemical localization of somatostatin in human brain. Peptides. 7:1986;877-884.
16. P.A. Berger, S.J. Watson, H. Akil, J.D. Barchas, Investigating opioid peptides in schizophrenia and depression, in: J.B. Martin, J.D. Barchas (Eds.), Neuropeptides in Neurologic and Psychiatric Disease, Raven Press, New York, 1986, pp. 309-333.
17. Bertabet R., Zigova T., Bakay R.A.E., Luskin M.B. Migration patterns of neonata subventricular zone progenitor cells transplanted into the neonatal striatum. Cell Transp. 5:1996;165-178.
18. V. Bigl, T. Arendt, D. Biesold, The nucleus basalis of Meynert during ageing and in dementing neuropsychiatric disorders, in: M. Steriade, D. Biesold (Eds.), Brain Cholinergic Systems, Oxford University Press, New York, 1990, pp. 364-386.
19. Bigl V., Arendt T., Fischer S., Werner M., Arendt A. The cholinergic system in aging. Gerontology. 33:1987;172-180.
20. Bouthenet M.L., Souil E., Martres M.P., Sokoloff P., Giros B., Schwartz J.C. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res. 564:1991;203-219.
21. Bowen D.M., Smith C.B., White P., Davison A.N. Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain. 99:1976;459-496.
22. Braak H., Braak E. Neuronal types in the basolateral amygdaloid nuclei of man. Brain Res. Bull. 11:1983;349-365.
23. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. (Berlin). 82:1991;239-259.
24. Breier A., Buchanan R.W., Elkashef A., Munson R.C., Kirkpatrick B., Gelladand F. Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Arch. Gen. Psychiatry. 49:1992;921-926.
25. Brockhaus H. Zur normalen und pathologischen Anatomie des Mandelkerngebietes. J. Psychol. Neurol. (Lpz). 49:1938;1-136.
26. Brockhaus H. Vergleichend-anatomische Untersuchungen über den Basalkern Komplex. J. Psychol. Neurol. (Lpz). 51:1942;57-95.
27. Brodal A. The amygdaloid nucleus in the rat. J. Comp. Neurol. 87:1947;1-15.
28. L.L. Butcher, The cholinergic system, in: G. Paxinos (Ed.), The Rat Nervous System, Academic Press, San Diego, 1995, pp. 1003-1015.
29. Buttlar-Brentano K. Pathohistologische Festellungen am Basalkern Schizophrener. J. Nerv. Ment. Dis. 116:1952;646-653.
30. Cameron H.A., Hazel T.G., Mckay R.G. Regulation of neurogenesis by growth factors and neurotransmitters [Review]. J. Neurobiol. 36:1998;287-306.
31. Candy J.M., Perry R.H., Thompson J.E., Johnson M., Oakley A.E. Neuropeptide localisation in the substantia innominata and adjacent regions of the human brain. J. Anat. 140:1985;309-327.
32. Carlsson M., Carlsson A. Interactions between glutamatergic and monaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease. Trends Neurosci. 13:1990;272-276.
33. Casanova M.F., Walker L.C., Whitehouse P.J., Price D.L. Abnormalities of the nucleus basalis in Down's syndrome. Ann. Neurol. 18:1985;310-313.
34. C.B. Courville, Pathology of the Central Nervous System, Part 4, Pacific, Mountainview, CA, 1937.
35. Davies P., Maloney A.J.F. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet. 2:1976;1403-1403.
36. S. De Lacalle, C.B. Saper, The cholinergic system in the primate brain: Basal forebrain and pontine-tegmental cell groups, in: F.E. Bloom, A. Björklund, T. Hökfelt (Eds.), Handbook of Chemical Neuroanatomy, Vol. 13: The Primate Nervous System, Part I, Elsevier Science B.V., Amsterdam, 1997.
37. de Olmos J., Heimer L. The concepts of the ventral striatopallidal system and extended amygdala. Ann. N.Y. Acad. Sci. 877:1999;1-31.
38. de Olmos J.S. A cupric-silver method for impregnation of terminal axon degeneration and its further use in staining granular argyrophilic neurons. Brain Behav. Evol. 2:1969;213-237.
39. J.S. de Olmos, Amygdala, in: G. Paxinos (Ed.), The Human Nervous System, Academic Press, San Diego, CA, 1990, pp. 583-710.
40. J.S. de Olmos, G.F. Alheid, C.A. Beltramino, Amygdala, in: G. Paxinos (Ed.), The Rat Nervous System, Academic Press, Sydney, 1985, pp. 223-334.
41. de Olmos J.S., Ingram W.R. The projection field of the stria terminalis in the rat brain. An experimental study. J. Comp. Neurol. 146:1972;303-334.
42. Deakin J.F.W., Slater P., Simpson M.D.C., Gilchrist A.C., Skan W.J., Royston M.C., Reynolds G.P., Cross A.J. Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J. Neurochem. 52:1989;1781-1786.
43. Deutch A.Y. Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and parkinson's disease. J. Neural Transm. 91:1993;197-221.
44. Divac I. Magnocellular nuclei of the basal forebrain project to neocortex, brainstem and olfactory bulb. Review of some functional correlates. Brain Res. 93:1975;385-398.
45. Dunnett S.B., Everitt B.J., Robbins T.W. The basal forebrain-cortical cholinergic system: Interpreting the functional consequences of excitotoxic lesions. Trends Neurosci. 14:1991;494-501.
46. Eriksson P.S., Perfilieva E., Bjork-Eriksson T., Alborn A.-M., Nordborg C., Peterson D.A., Gage F.H. Neurogenesis in the adult hippocampus. Nature Medicine. 4:1998;1313-1317.
47. Fallon J.H. The islands of Calleja complex of rat basal forebrain. II. Connections of medium and large sized cells. Brain Res. Bull. 10:1983;775-793.
48. Ferrier I.N., Roberts G.W., Crow T.J., Johnstone E.C., Owens D.G.C., Lee Y., O'Shaughnessey D., Adrian T.E., Polak J.M., Bloom S.R. Reduced cholecystokinin and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophrenia. Life Sci. 33:1983;475-482.
49. Friston K.J., Frith C.D. Schizophrenia: A disconnection syndrome? Clin. Neurosci. 3:1995;89-97.
50. Fudge J.L., Powers J.M., Haber S.N., Caine E.D. Considering the role of the amygdala in psychotic illness - a clinicopathological correlation. J. Neuropsychiat. Clin. Neurosci. 10:1998;383-394.
51. Gaspar P., Berger B., Lesur A., Borsotti J.P., Febvret A. Somatostatin 28 and neuropeptide Y innervation in the septal area and related cortical and subcortical structures of the human brain. Distribution, relationships and evidence for differential coexistence. Neuroscience. 22:1987;49-73.
52. Gillberg C., Terenius L., Lönnerholm G. Endorphin activity in childhood psychosis. Arch. Gen. Psychiatry. 42:1985;780-783.
53. P. Gloor, The Temporal Lobe and Limbic System, Oxford University Press, New York, 1997.
54. Grace A.A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia. Neuroscience. 41:1991;1-24.
55. D.I. Graham, J.H. Adams, T.A. Gennarelli, Pathology of brain damage in head injury, in: P.R. Cooper (Ed.), Head Injury, Williams and Wilkins, Baltimore, MD, 1993, pp. 91-113.
56. J.A. Gray, A model of the limbic system and basal ganglia: Applications to anxiety and schizophrenia, in: M.S. Gazzaniga (Ed.), The Cognitive Neurosciences, MIT Press, Cambridge, MA, 1995, pp. 1165-1176.
57. A.M. Graybiel, C.W. Ragsdale, Biochemical anatomy of the striatum, in: P.C. Emson (Ed.), Chemical Neuroanatomy, Raven, New York, 1983, pp. 427-504.
58. Griffon N., Crocq M.A., Pilon C., Martres M.P., Mayerova A., Uyanik G., Burgert E., Duval F., Macher J.P., Javoy-Agid F., Tamminga C.A., Schwartz J.C., Sokoloff P. Dopamine D3 receptor gene: organization, transcript variants, and polymorphism associated with schizophrenia. Am. J. Med. Genet. 67:1996;63-70.
59. H.J. Groenewegen, Cortical-subcortical relationships and the limbic forebrain, in: Trimble, J. Cummings (Eds.), Contemporary Behavioral Neurology, Butterworth-Heineman, Boston, 1996, pp. 29-48.
60. H.J. Groenewegen, H.W. Berendse, Anatomical relationships between the prefrontal cortex and the basal ganglia in the rat, in: A.M. Thierry, J. Glowinski, P.S. Goldman-Rakic, Y. Christen (Eds.), Motor and Cognitive Functions of the Prefrontal Cortex, Springer-Verlag, Berlin, Heidelberg, 1994, pp. 31-77.
61. Groenewegen H.J., Berendse H.W., Wolters J.G., Lohman A.H. The anatomical relationship of the prefrontal cortex with the striatopallidal system, the thalamus and the amygdala: evidence for a parallel organization, discussion 116. Prog. Brain Res. 85:1990;95-116.
62. Groenewegen H.J., Russchen F.T. Organization of the efferent projections of the nucleus accumbens to pallidal, hypothalamic, and mesencephalic structures: a tracing and immunohistochemical study in the cat. J. Comp. Neurol. 223:1984;347-367.
63. Gurevich E.V., Bordelon Y., Shapiro R.M., Arnold S.E., Gur R.E., Joyce J.N. Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study. Arch. Gen. Psychiatry. 54:1997;225-232.
64. Haber S. Anatomical relationship between the basal ganglia and the basal nucleus of Meynert in human and monkey forebrain. Proc. Natl. Acad. Sci. USA. 84:1987;1408-1412.
65. Haber S.N., Fudge J.L. The interface between dopamine neurons and the amygdala - Implications for schizophrenia. Schrizophr. Bull. 23:1997;471-482.
66. Haber S.N., Kunishio K., Mizobuchi M., Lynd-Balta E. The orbital and medial prefrontal circuit through the primate basal ganglia. J. Neurosci. 15:1995;4851-4867.
67. S.N. Haber, E. Lynd-Balta, W.P.T.M. Spooren, Integrative aspects of basal ganglia circuitry, in: G. Percheron, J.S. McKenzie, J. Féger (Eds.), The Basal Ganlia IV, Plenum Press, New York, 1994, pp. 71-80.
68. Haber S.N., Nauta W.J. Ramifications of the globus pallidus in the rat as indicated by patterns of immunohistochemistry. Neuroscience. 9:1983;245-260.
69. Haber S.N., Watson S.J. The comparative distribution of enkephalin, dynorphin and substance P in the human globus pallidus and basal forebrain. Neuroscience. 14:1985;1011-1024.
70. Haber S.N., Wolfe D.P., Groenewegen H.J. The relationship between ventral striatal efferent fibers and the distribution of peptide-positive woolly fibers in the forebrain of the rhesus monkey. Neuroscience. 39:1990;323-338.
71. Halliday G.M., Cullen K., Cairns M.J. Quantitation and three-dimensional reconstruction of Ch4 nucleus in the human basal forebrain. Synapse. 15:1993;1-16.
72. Hedreen J.C., DeLong M.R. Organization of striatopallidal, striatonigal, and nigrostriatal projections in the Macaque. J. Comp. Neurol. 304:1991;569-595.
73. L. Heimer, The olfactory cortex and the ventral striatum, in: K.E. Livingston, O. Hornykiewicz, (Eds.), Limbic Mechanisms, Plenum Press, New York, 1978, pp. 95-187.
74. Heimer L., Alheid G.F., de Olmos J.S., Groenewegen H.J., Haber S.N., Harlan R.E., Zahm D.S. The accumbens: beyond the core-shell dichotomy. J. Neuropsychiat. Clin. Neurosci. 9:1997;354-381.
75. L. Heimer, J. de Olmos, G.F. Alheid, J. Pearson, M. Sakamoto, J. Marksteiner, R.C. Switzer III, The human basal forebrain, part 2, in: F.E. Bloom, A. Björklund, T. Hökfelt (Eds.), Handbook of Chemical Neuroanatomy, Vol.15, Elsevier, Amsterdam, 1999, pp. 57-226.
76. Heimer L., de Olmos J., Alheid G.F., Zaborszky L. 'Perestroika' in the basal forebrain: opening the border between neurology and psychiatry. Prog. Brain Res. 87:1991;109-165.
77. Heimer L., Harlan R.E., Alheid G.F., Garcia M., de Olmos J. Substantia innominata: A notion which impedes clinical-anatomical correlations in neuropsychiatric disorders. Neuroscience. 76:1997;957-1006.
78. L. Heimer, R.D. Wilson, The subcortical projections of allocortex: Similarities in the neuronal associations of the hippocampus, the piriform cortex and the neocortex, in: M. Santini (Ed.), Golgi Centennial Symposium Proceedings, Raven Press, New York, 1975, pp. 173-193.
79. L. Heimer, D.S. Zahm, G.F. Alheid, Basal Ganglia, in: G. Paxinos (Ed.), The Rat Nervous System, 2nd edition, Academic Press, San Diego, CA, 1995, pp. 579-628.
80. Heimer L., Zahm D.S., Churchill L., Kalivas P.W., Wohltmann C. Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience. 41:1991;89-125.
81. 2+-binding proteins in human neurodegenerative disorders. Trends Neurosci. 15:1992;259-264.
82. Hilpert P. Der Mandelkern des Menschen. I. Cytoarchitektonik und Faserverbindungen. J. Psychol. Neurol. (Lpz.). Bd.36:1928;S.44-77.
83. Hurd Y.L., Herkenham M. The human neostriatum shows compartmentalization of neuropeptide gene expression in dorsal and ventral regions: An in situ hybridization histochemical analysis. Neuroscience. 64:1995;571-597.
84. Hyman B.T., Gomez-Isla T. Alzheimer's disease is a laminar, regional, and neural system specific disease, not a global brain disease. Neurobiol. Aging. 15:1994;353-354.
85. Hyman B.T., Van Hoesen G.W., Kromer L.J., Damasio A.R. Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann. Neurol. 20:1986;472-481.
86. Ichimiya Y., Emson P.C., Mountjoy C.Q., Lawson D.E.M., Iizuka R. Calbindin-immunoreactive cholinergic neurons in the nucleus basalis of Meynert in Alzheimer's disease. Brain Res. 499:1989;402-406.
87. Jakob J., Beckmann H. Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J. Neural Transm. 65:1986;303-326.
88. Jaskiw G.E., Weinberger D.R. Dopamine and schizophrenia - a cortically corrective perspective. Sem. Neurosci. 4:1992;179-188.
89. K. Jellinger, Neuromorphological background of pathochemical studies in major psychoses, in: H. Beckmann, P. Riederer (Eds.), Pathochemical Markers in Major Psychoses, Springer-Verlag, Berlin, 1985, pp. 1-23.
90. Joel D., Weiner I. The organization of the basal ganglia-thalamocortical circuits: Open interconnected rather than closed segregated. Neuroscience. 63:1994;363-379.
91. Johnston J.B. Further contribution to the study of the evolution of the forebrain. J. Comp. Neurol. 35:1923;337-481.
92. Jones E.G., Burton H., Saper C.B., Swanson L.W. Midbrain, diencephalic and cortical relationships of the basal nucleus of Meynert and associated structures in primates. J. Comp. Neurol. 167:1976;385-419.
93. Joyce J.N. The dopamine hypothesis of schizophrenia: Limbic interactions with serotonin and norepinephrine. Psychopharmacology. 112:1993;S16-S34.
94. Joyce J.N., Gurevich E.V. Dopamine D3 receptor: From anatomy to neuropsychiatry. Neurosci. News. 2:1999;11-21.
95. Joyce J.N., Meador-Woodruff J.H. Linking the family of D2 receptors to neuronal circuits in human brain: insights into schizophrenia. [Review] [78 refs]. Neuropsychopharmacology. 16:1997;375-384.
96. Kaufmann W.A., Barnas U., Maier J., Saria A., Alheid G.F., Marksteiner J. Neurochemical compartments in the human forebrain: evidence for a high density of secretoneurin-like immunoreactivity in the extended amygdala. Synapse. 26:1997;114-130.
97. Kievit J., Kuypers H.G.J.M. Basal forebrain and hypothalamic connections to prefrontal and parietal cortex in the rhesus monkey. Science. 187:1975;660-662.
98. V.E. Koliatsos, L.J. Martin, D.L. Price, Efferent organization of the mammalian basal forebrain, in: M. Steriade, D. Biesold (Eds.), Brain Cholinergic System, Oxford University Press, Oxford, 1990, pp. 120-152.
99. Koliatsos V.E., Martin L.J., Walker L.C., Richardson R.T., DeLong M.R., Priceand D.L. Topographic, non-collateralized basal forebrain projections to amygdala, hippocampus, and anterior cingulate cortex in the rhesus monkey [published errata appear in Brain Res. (1989) Jan. 23, 478(1):204 and (1989) May 15, 487(1):204]. Brain Res. 463:1988;133-139.
100. Lesur A., Gaspar P., Alvarez C., Berger B. Chemoanatomic compartments in the human bed nucleus of the stria terminalis. Neuroscience. 32:1989;181-194.
101. B. Levant, G. Bissette, C.B. Nemeroff, Neurotensin, in: C.B. Nemeroff (Ed.), Neuropeptides in Psychiatry, APA Press, Washington, 1990, pp. 149-168.
102. Levin H.S., Amparo E., Eisenberg H.M., Williams D.H., High W.M. Jr., Craig B., McArdle C.B., Weiner R.L. Magnetic resonance imaging and computerized tomography in relation to the neurobehavioral sequelae of mild and moderate head injuries. J. Neurosurg. 66:1987;706-713.
103. Luskin M.B., Price J.L. The topographic organization of associational fibers of the olfactory system in the rat, including centrifugal fibers to the olfactory bulb. J. Comp. Neurol. 216:1983;264-291.
104. Mai J.K., Stephens P.H., Hope A., Cuello A.C. Substance P in the human brain. Neuroscience. 17:1986;709-739.
105. Martin L.J., Powers R.E., Dellovade T.L., Price D.L. The bed nucleus-amygdala continuum in human and monkey. J. Comp. Neurol. 309:1991;445-485.
106. Matthysse S. Antipsychotic drug actions: A clue to the neuropathology of schizophrenia? Fed. Proc. 32:1973;200-205.
107. McGuire P.K., Silbersweig D.A., Murray R.M., David A.S., Frackowiak R.S., Frithand C.D. Functional anatomy of inner speech and auditory verbal imagery. Psychol. Med. 26:1996;29-38.
108. McGuire P.K., Silbersweig D.A., Wright I., Murray R.M., Frackowiak R.S., Frithand C.D. The neural correlates of inner speech and auditory verbal imagery in schizophrenia: relationship to auditory verbal hallucinations. Brit. J. Psychiatry. 169:1996;148-159.
109. Mega M.S., Cummings J.L. Frontal-subcortical circuits and neuropsychiatric disorders. J. Neuropsychiatry. 6:1994;358-370.
110. 28k. J. Comp. Neurol. 365:1996;628-639.
111. Merriam A.E., Aronson M.K., Gaston P., Wey S.-U., Katz I. The psychiatric symptoms of Alzheimer's disease. J. Am. Geriatr. Soc. 36:1988;7-12.
112. Mesulam M.M., Geula C. Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain; observations based on the distribution of acetylcholinesterase and choline acetytransferase. J. Comp. Neurol. 274:1988;216-240.
113. Mesulam M.M., Mash L., Herch L., Brothwell M., Geula C. Cholinergic innervation of the human striatum, globus pallidus, subthalamic nucleus, substantia nigra and red nucleus. J. Comp. Neurol. 323:1992;252-268.
114. Mesulam M.M., Mufson E.J. Neural inputs into the nucleus basalis of the substantia innominata (Ch4) in the rhesus monkey. Brain. 107:1984;253-274.
115. Mesulam M.M., Mufson E.J., Levey A.I., Wainer B.H. Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J. Comp. Neurol. 214:1983;170-197.
116. Mesulam M.M., Mufson E.J., Wainer B.H. Three-dimensional representation and cortical projection topography of the nucleus basalis (Ch4) in the macaque: concurrent demonstration of choline acetyltransferase and retrograde transport with a stabilized tetramethylbenzidine method for horseradish peroxidase. Brain Res. 367:1986;301-308.
117. Mesulam M.M., Mufson E.J., Wainer B.H., Levey A.I. Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience. 10:1983;1185-1201.
118. Mesulam M.M., Van Hoesen G.W. Acetylcholinesterase-rich projections from the basal forebrain of the rhesus monkey to neocortex. Brain Res. 109:1976;152-157.
119. Meyer G., Gonzalez-Hernandez T., Carrillo-Padilia F., Ferres-Torres R. Aggregations of granule cells in the basal forebrain (islands of Calleja). A Golgi and cytoarchitectonic study in different mammals including man. J. Comp. Neurol. 284:1989;405-478.
120. Millhouse O.E. Granule cells of the olfactory tubercle and the question of the Islands of Calleja. J. Comp. Neurol. 265:1987;1-24.
121. Modell J.G., Mountz J.M., Curtis G.C., Greden J.F. Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder. J. Neuropsychiat. Clin. Neurosci. 1:1989;27-36.
122. Mufson E.J., Benoit R., Mesulam M.M. Immunohistochemical evidence for a possible somatostatin- containing amygdalostriatal pathway in normal and Alzheimer's disease brain. Brain Res. 453:1988;117-128.
123. Muir J.L., Everitt B.J., Robbins T.W. AMPA-induced excitotoxic lesions of the basal forebrain: A significant role for the cortical cholinergic system in attentional function. J. Neurosci. 14:1994;2313-2326.
124. Murray R.M., Lewis S.R. Is schizophernia a developmental disorder? Brit. Med. J. 295:1987;681-682.
125. Nair N.P.V., Lal S., Bloom D.M. Cholecystokinin and schizophrenia, Prog. Brain Res. 65:1986;237-258.
126. Nakano I., Hirano A. Neuron loss in the nucleus basalis of Meynert in parkinsonism-dementia complex of Guam. Ann. Neurol. 13:1983;87-91.
127. Nasrallah H.A., Fowler R.C., Judd L.L. Schizophrenia-like illness following head injury. Psychosoma. 22:1981;359-361.
128. Nauta W.J.H., Smith G.P., Faull R.L.M., Domesick V.B. Efferent connections and nigral afferents of the nucleus accumbens septi in the rat. Neuroscience. 3:1978;385-401.
129. Nemeroff C.B. Neurotensin: Perchance an endogenous neuroleptic? Biol. Psychiatry. 15:1980;283-302.
130. O'Donnell P., Grace A.A. Dysfunctions in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters. Schizophr. Bull. 24:1998;267-283.
131. Pakkenberg B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch. Gen. Psychiatry. 47:1990;1023-1028.
132. Pantelis C., Barnes T.R.E., Nelson H.E., Tanner S., Weatherley L., Owen A.M., Robbins T.W. Frontal-striatal cognitive deficits in patients with chronic schizophrenia. Brain. 120:1997;1823-1843.
133. Pearson R.C.A., Gatter K.C., Powell T.P.S. Retrograde cell degeneration in the basal nucleus of the monkey and man. Brain Res. 261:1983;321-326.
134. Price J.L., Amaral D.J. An autoradiographic study of the projections of the central nucleus of the monkey amygdala. J. Neurosci. 1:1981;1242-1259.
135. J.L. Price, S.T. Carmichael, W.C. Drevets, Networks related to the orbital and medial prefrontal cortex. A substrate for emotional behavior?, in: G. Holstege, R. Bandler, C.B. Saper (Eds.), The Emotional Motor System, Prog. Brain Res. 107 (1996) pp. 461-484.
136. J.L. Price, F.T. Russchen, D.G. Amaral, The limbic region. II. The amygdaloid complex, in: A. Björklund, T. Hökfelt, L.W. Swanson (Eds.), in: Handbook of Chemical Neuroanatomy Integrated Systems of the CNS, Elsevier, Amsterdam, 1987, pp. 279-388.
137. K.B. Reichert, Der Bau des Menschlichen Gehirns durch Abbildung mit erlauterndem Texte, 2 Vols, Engelmann, Leipzig, 1859.
138. Reil J.C. Untersuchungen über den Bau des grossen Gehirn im Menschen. Arch. Physiol. (Halle). 9:1809;136-208.
139. Robbins T.W. The case for frontostriatal dysfunction in schizophrenia. Schrizophr. Bull. 16:1990;391-402.
140. G.W. Roberts, M.C. Royston, D.R. Weinberger, Schizophrenia, in: D.I. Graham, P.L. Lantos (Eds.), Greenfield's Neuropathology, 6th Edition, Oxford University Press, New York, 1997, pp. 897-929.
141. Rossor M., Svendsen C., Hent S., Montjoy C., Roth M., Iversen L. The substantia innominata in Alzheimer's disease: A histochemical and biochemical study of cholinergic marker enzymes. Neurosci. Lett. 28:1982;217-222.
142. N. Sakamoto, J. Pearson, K. Shinoda, G.F. Alheid, J. de Olmos, L. Heimer, The human basal forebrain, part I: An Overview, in: F.E. Bloom, A. Björklund, T. Hökfelt (Eds.), Handbook of Chemical Neuroanatomy. Vol. 15, Elsevier, Amsterdam, 1999, 1-56.
143. Salloway S., Cummings J. Subcortical disease and neuropsychiatric illness. J. Neuropsychiatry. 6:1994;93-99.
144. Sanides F. Die Insulae terminales des Erwachsenen Gehirns des Menschen. J. Hirnforsch. 3:1957;243-273.
145. Sarter M., Bruno J.P. Abnormal regulation of corticopetal cholinergic neurons and impaired information processing in neuropsychiatric disorders. Trends Neurosci. 22:1999;67-74.
146. Scheibel A.B., Kovelman J.A. Disorientation of the hippocampal pyramidal cells and its processes in the schizophrenic patient. Biol. Psychiatry. 16:1981;101-102.
147. N.A. Schmajuk, M. Tyberg, The hippocampal lesion model of schizophrenia, in: A.A. Boulton, G.B. Baker, M.T.P. Martin-Iverson (Eds.), Neuromethods: Animal Models in Psychiatry, 1, Vol. 19, Humana Press, Clifton, NJ, 1990.
148. Schneider G.E. Is it really better to have your brain lesion early? A revision of the Kennard Principle. Neuropsychologia. 17:1979;557-583.
149. Schwaber J.S., Rogers W.T., Satoh K., Fibiger H.C. Distribution and organization of cholinergic neurons inthe rat forebrain demonstrated by computer-aided data acquisition and three-dimensional reconstruction. J. Comp. Neurol. 263:1987;309-325.
150. Sedvall G., Farde L. Chemical brain anatomy in schizophrenia. Lancet. 346:1995;743-749.
151. Silbersweig D.A., Stern E., Frith C., Cahill C., Holmes A., Grootoonk S., Seaward J., McKenna P., Chua S.E., Schnorr L., Jones T., Frackowiak R.S.J. A functional neuroanatomy of hallucinations in schizophrenia. Nature. 378:1995;176-179.
152. Simic G., Mrzljak L., Fucic A., Winblad B., Lovric H., Kostovic I. Nucleus subputaminalis (Ayala): The still disregarded magnocellular component of the basal forebrain may be human specific and connected with the cortical speech area [Review]. Neuroscience. 89:1999;73-89.
153. Slater E., Beard A.W. The schizophrenia-like psychoses of epilepsy. Brit. J. Psychiatry. 109:1963;95-150.
154. Smiley J.F., Mesulam M.M. Cholinergic neurons of the nucleus basalis of Meynert receive cholinergic, catecholaminergic and GABAergic synapses: An electron microscopic investigation in the monkey. Neuroscience. 88:1999;241-255.
155. Sokoloff P., Giros B., Martres M.P., Bouthenet M.L., Schwartz J.C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature. 347:1990;146-151.
156. Sorvari H., Soininen H., Pitkanen A. Calbindin-D28K-immunoreactive cells and fibres in the human amygdaloid complex. Neuroscience. 75:1996;421-443.
157. Sorvari H., Soininen H., Pitkanen A. Calretinin-immunoreactive cells and fibers in the human amygdaloid complex. J. Comp. Neurol. 369:1996;188-208.
158. M. Steriade, G. Buzsaki, Parallel activation of thalamic and cortical neurons by brainstem and basal forebrain cholinergic systems, in: M. Steriade, D. Biesold (Eds.), Brain Cholinergic Systems, Oxford University Press, New York, 1990, pp. 3-64.
159. Steriade M., Parent A., Pare D., Smith Y. Cholinergic and non-cholinergic neurons of the cat basal forebrain project to the reticular and mediodorsal thalamic nuclei. Brain Res. 408:1987;372-376.
160. Stevens J.R. An anatomy of schizophrenia? Arch. Gen. Psychiatry. 29:1973;177-189.
161. Stevens J.R. Abnormal reinnervation as a basis for schizophrenia: a hypothesis. Arch. Gen. Psychiatry. 49:1992;238-243.
162. Stevens J.R. Anatomy of schizophenia revisited. Schrizophr. Bull. 23:1997;373-383.
163. Strenge H., Braak E., Braak H. Über den Nucleus striae terminalis im Gehirn des erwachsenen Menschen. Z. Mikrosk. Anat. Forsch. 91(1.S):1977;105-118.
164. 3 dopamine receptor mRNA is widely expressed in the human brain. Brain Res. 779:1998;58-74.
165. Swerdlow N.R., Koob G.F. Dopamine, schizophrenia, mania and depression: Toward a unified hypothesis of cortico-striato-pallido-thalamic function. Behav. Brain Sci. 10:1987;197-245.
166. Talbot K., Woolf N.J., Butcher L.L. Feline Islands of Calleja complex: I. Cytoarchitectural organization and comparative anatomy. J. Comp. Neurol. 275:1988;553-579.
167. Talbot K., Woolf N.J., Butcher L.L. Feline islands of Calleja complex: II.Cholinergic and cholinesterasic features. J. Comp. Neurol. 275:1988;580-603.
168. Terry R.D., Davies P. Dementia of the Alzheimer type. Annu. Rev. Neurosci. 3:1980;77-95.
169. E.F. Torrey, M.R. Peterson, Schizophrenia and the limbic system, Lancet (1974) 942-946.
170. Tourtellotte W.G., Van Hoesen G.W., Hyman B.T., Tikoo R.K., Damasio A.R. Alz-50 immunoreactivity in the thalamic reticular nucleus in Alzheimer's disease. Brain Res. 515:1990;227-234.
171. Ulfig N. Configuration of the magnocellular nuclei in the basal forebrain of the human adult. Acta Anat. 134:1989;100-105.
172. G.W. Van Hoesen, The differential distribution, diversity and sprouting of cortical projections to the amygdala in the rhesus monkey, in: Y. Ben-Ari (Ed.), The Amygdaloid Complex, INSERM Symposium 20, Elsevier/North-Holland Biomedial Press, Amsterdam, 1981, pp. 77-90.
173. Van Hoesen G.W. Ventromedial temporal lobe anatomy, with comments on Alzheimer's disease and temporal injury. J. Neuropsychiat. Clin. Neurosci. 9:1997;331-341.
174. Van Hoesen G.W., Hyman B.T., Damasio A.R. Entorhinal cortex pathology in Alzheimer's disease. Hippocampus. 1:1991;1-8.
175. A. Violon, Post-traumatic psychoses, in: J. Bribaye, L. Calliauv, F. Loew, R. van den Bergh (Eds.), Personality and Neurosurgery, Acta Neurochirurgica Supplementum 44, Springer-Verlag Wien, New York, 1988, pp. 67-69.
176. Voorn P., Brady L.S., Berendse H.W., Richfield E.K. Densitometrical analysis of opioid receptor ligand binding in the human striatum I: Distribution of μ opioid receptor defines shell and core of the ventral striatum. Neuroscience. 75:1996;777-792.
177. Völsch M. Zur vergleichenden Anatomie des Mandelkerns und seiner Nachbargebilde. I. Teil. Arch. Mikrosk. Anat. 68:1906;573-683.
178. Völsch M. Zur vergleichenden Anatomie des Mandelkerns und seiner Nachbarogebilde. II. Teil. Arch. Mikrosk. Anat. 76:1910;373-523.
179. B.H. Wainer, M.M. Mesulam, Ascending cholinergic pathways in he rat brain, in: M. Steriade, D. Biesold (Eds.), Brain Cholinergic Systems, Oxford University Press, Oxford, 1990, pp. 65-119.
180. Walker L.C., Kitt C.A., DeLong M.R., Price D.L. Noncollateral projections of basal forebrain neurons to frontal and parietal neocortex in primates. Brain Res. Bull. 15:1985;307-314.
181. Walter A., Mai J.K., Jimenez-Hartel W. Mapping of neuropeptide Y-like immunoreactivity in the human forebrain. Brain Res. Bull. 24:1990;297-311.
182. Walter A., Mai J.K., Lanta L., Gorcs T. Differential distribution of immunohistochemical markers in the bed nucleus of the stria terminalis in the human brain. J. Chem. Neuroanat. 4:1991;281-298.
183. D.R. Weinberger, The pathogenesis of schizophrenia: A neurodevelopmental theory, in: H.A. Nasrallah, D.R. Weinberger (Eds.), The Neurology of Schizophrenia, Elsevier, Amsterdam, 1986, pp. 387-405.
184. D.R. Weinberger, Anteromedial temporal-prefrontal connectivity: A functional neuroanatomical system implicated in schizophenia, in: B.J. Carroll, J.E. Barrett (Eds.), Psychopathology and the Brain, Raven Press, New York, 1991, pp. 25-43.
185. Weinberger D.R., Lipska B.K. Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: A search for common ground. Schizophr. Res. 16:1995;87-110.
186. Whitehouse P.J., Price D.L., Clark A.W., Coyle J.T., DeLong M.R.
187. Wilcock G.K., Esiri M.M., Bowen D.M., Smith C.C.T. The nucleus basalis in Alzheimers's disease; cell counts and cortical biochemistry. Neuropathol. App. Neurobiol. 9:1983;175-179.
188. Woodruff P.W.R., Wright I.C., Shuriquie N., Russouw H., Rushe T., Howard R.J., Graves M., Bullmore E.T., Murray R.M. Structural brain abnormalities in male schizophrenics reflect fronto-temporal dissociation. Psychol. Med. 27:1997;1257-1266.
189. Wu C.K., Mesulam M.M., Geula C. Age-related loss of calbindin from human basal forebrain cholinergic neurons. NeuroReport. 8:1997;2209-2213.
190. Zaborszky L., Alheid G.F., Beinfeld M.C., Eiden L.E., Heimer L., Palkovits M. Cholecystokinin innervation of the ventral striatum: a morphological and radioimmunological study. Neuroscience. 14:1985;427-453.
191. L. Zaborszky, W.E. Cullinan, A. Braun, Afferents to basal forebrain cholinergic projection neurons: An update, in: T.C. Napier, P.W. Kalivas, L. Hanin (Eds.), The Basal Forebrain: Anatomy to Function, Advances in Experimental Medicine and Biology, Vol. 295, Plenum Press, New York, 1991, pp. 43-100.
192. Zahm D.S., Brog J.S. On the significance of subterritories in the 'accumbens' part of the rat ventral striatum. Neuroscience. 50:1992;751-767.
193. Zezula J., Cortés R., Probst A., Palacios J.M. Benzodiazepine receptor sites in the human brain: Autoradiographic mapping. Neuroscience. 25:1988;771-795.